Titan Pharmaceuticals, Inc. (TTNP)

NASDAQ: TTNP · IEX Real-Time Price · USD

5.43

-0.11 (-1.99%)

At close: Jul 2, 2024, 4:00 PM

5.13

-0.30 (-5.52%)

After-hours: Jul 2, 2024, 4:44 PM EDT

Titan Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 1995
Net Income	-5.57	-10.21	-8.78	-18.24	-16.46	Upgrade
Depreciation & Amortization	0.11	0.2	0.22	0.29	0.24	Upgrade
Share-Based Compensation	1.04	1.4	1.54	0.01	0.57	Upgrade
Other Operating Activities	-2.67	0.43	-0.89	0.74	0.2	Upgrade
Operating Cash Flow	-7.09	-8.18	-7.9	-17.2	-15.45	Upgrade
Capital Expenditures	-0	0	-0.02	-0.54	-0.26	Upgrade
Acquisitions	0.73	0	0	0	0	Upgrade
Investing Cash Flow	0.73	0	-0.02	-0.54	-0.26	Upgrade
Share Issuance / Repurchase	0	4.98	8.84	18.88	11.27	Upgrade
Debt Issued / Paid	0.5	0	0	-0.95	0	Upgrade
Other Financing Activities	9.5	-	-	-	-	Upgrade
Financing Cash Flow	10	4.98	8.84	17.93	11.27	Upgrade
Net Cash Flow	3.64	-3.2	0.92	0.19	-4.43	Upgrade
Free Cash Flow	-7.09	-8.18	-7.92	-17.74	-15.7	Upgrade
Free Cash Flow Margin	-3855.43%	-1469.12%	-519.13%	-366.74%	-602.73%	Upgrade
Free Cash Flow Per Share	-9.43	-12.18	-16.28	-94.05	-409.95	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).